仲怀琴,秦鹤锦,戴宇翔,常书福,钱菊英,葛均波

• 1:复旦大学附属中山医院心内科上海心血管病研究所
• 2:华东疗养院老年病科

摘要(Abstract)：

目的探讨高尿酸血症对于肾功能正常的急性冠状动脉综合征(ACS)患者接受经皮冠状动脉介入治疗(PCI)后发生对比剂肾病(CIN)的预测意义。方法回顾性收集2016年1月至2016年6月复旦大学附属中山医院心内科住院并接受PCI且基础肾功能正常的ACS患者共596例,根据尿酸水平将血尿酸水平正常的患者设为对照组(343例),将高尿酸血症患者设为高尿酸组(253例)。分析两组患者PCI后CIN的发生情况,并对CIN的危险因素进行单因素和多因素回归分析。结果两组患者年龄、性别、高血压病、糖尿病、吸烟、冠心病史、冠状动脉旁路移植术史等比较,差异均无统计学意义(均P>0.05);高尿酸组超敏C反应蛋白水平[18.2(7.6,98.5)mg/L比15.9(5.2,68.7)mg/L,P=0.038]、CIN发生率(19.8%比11.4%,P=0.005)显著高于对照组,差异均有统计学意义。以血尿酸水平作为连续变量,logistic多因素回归分析显示,左心室射血分数(LVEF)<50%(OR 2.57,95%CI 1.11～5.91,P=0.027)、血尿酸(OR 1.06,95%CI 1.01～1.11,P=0.015)、估算的肾小球滤过率(eGFR)(OR 0.98, 95%CI 0.95～0.99,P=0.040)、血细胞比容(HCT)(OR 0.96,95%CI0.82～0.99,P=0.031)、糖化血红蛋白(HbA_(1C))(OR 1.51,95%CI 1.05～2.60,P=0.023)、对比剂剂量(OR 2.60,95%CI 1.45～4.67,P=0.001)是CIN的独立危险因素。以高尿酸血症作为分类变量,logistic多因素回归分析显示,LVEF<50%(OR 2.53,95%CI 1.10～5.78,P=0.028)、血尿酸水平(OR 1.77,95%CI 1.21～3.40,P=0.009)、eGFR(OR 0.98,95%CI 0.95～0.99,P=0.041)、HCT(OR 0.96, 95%CI0.81～0.99,P=0.034)、HbA_(1C)(OR 1.49, 95%CI 1.03～2.72,P=0.028)和对比剂剂量(OR 2.57, 95%CI1.44～4.58, P=0.001)是CIN的独立危险因素。结论对于肾功能正常的ACS患者,高尿酸血症是PCI术后发生CIN的独立危险因素。

关键词(KeyWords)： 尿酸;急性冠状动脉综合征;经皮冠状动脉介入治疗;对比剂肾病

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金青年科学基金项目(81300095);; 复旦大学附属中山医院优秀青年基金(2017)

作者(Author): 仲怀琴,秦鹤锦,戴宇翔,常书福,钱菊英,葛均波

参考文献(References)：

• [1]F?hling M,Seeliger E,Patzak A,et al.Understanding and preventing contrast-induced acute kidney injury.Nat Rev Nephrol,2017,13(3):169-180.
• [2]Mc Cullough PA,Choi JP,Feghali GA,et al.Contrast-induced acute kidney injury.J Am Coll Cardiol,2016,68(13):1465-1473.
• [3]Wichmann JL,Katzberg RW,Litwin SE,et al.Contrast-induced nephropathy.Circulation,2015,132(20):1931-1936.
• [4]Mc Cullough PA.Contrast-induced nephropathy:definitions,epidemiology,and implications.Interv Cardiol Clin,2014,3(3):357-362.
• [5]王若蒙,张拓,张维峰,等.两种对比剂诱发的急性肾损伤诊断标准在冠状动脉介入术后患者中的应用比较.中国介入心脏病学杂志,2017,25(1):7-12.
• [6]Duran M,Kalay N,Akpek M,et al.High levels of serum uric acid predict severity of coronary artery disease in patients with acute coronary syndrome.Angiology,2012,63(6):448-452.
• [7]Yang Y,Tian J,Zeng C,et al.Relationship between hyperuricemia and risk of coronary heart disease in a middle-aged and elderly Chinese population.J Int Med Res,2017,45(1):254-260.
• [8]Windecker S,Kolh P,Alfonso F,et al.2014 ESC/EACTSguidelines on myocardial revascularization:the task force on myocardial revascularization of the European Society of Cardiology(ESC)and the European Association for Cardio-Thoracic Surgery(EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions(EAPCI).Eur Heart J,2014,35(37):2541-2619.
• [9]Chalikias G,Drosos I,Tziakas DN.Contrast-induced acute kidney injury:an update.Cardiovasc Drugs Ther,2016,30(2):215-228.
• [10]Katsiki N,Athyros VG,Karagiannis A,et al.Contrast-induced nephropathy:an"all or none"phenomenon?Angiology,2015,66(6):508-513.
• [11]Ortega LM,Harmouch I,Nayer A.Contrast-induced nephropathy:pathogenesis and new therapeutic options for prevention.Am J Ther,2015,22(6):469-476.
• [12]Azzalini L,Spagnoli V,Ly HQ.Contrast-induced nephropathy:from pathophysiology to preventive strategies.Can J Cardiol,2016,32(2):247-255.
• [13]Toprak O.Conflicting and new risk factors for contrast induced nephropathy.J Urol,2007,178(6):2277-2283.
• [14]Barbieri L,Verdoia M,Schaffer A,et al.Uric acid levels and the risk of contrast induced nephropathy in patients undergoing coronary angiography or PCI.Nutr Metab Cardiovasc Dis,2015,25(2):181-186.
• [15]Liu Y,Tan N,Chen J,et al.The relationship between hyperuricemia and the risk of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with relatively normal serum creatinine.Clinics(Sao Paulo),2013,68(1):19-25.
• [16]Guo W,Liu Y,Chen JY,et al.Hyperuricemia is an independent predictor of contrast-induced acute kidney injury and mortality in patients undergoing percutaneous coronary intervention.Angiology,2015,66(8):721-726.
• [17]Toprak O,Cirit M,Esi E,et al.Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease.Catheter Cardiovasc Interv,2006,67(2):227-235.
• [18]Okino S,Fukuzawa S,Inagaki M,et al.Hyperuricemia as a risk factor for progressive renal insufficiency after coronary intervention in patients with chronic kidney disease.Cardiovasc Interv Ther,2010,25(2):105-111.
• [19]Zuo T,Jiang L,Mao S,et al.Hyperuricemia and contrast-induced acute kidney injury:A systematic review and meta-analysis.Int JCardiol,2016,224:286-294.
• [20]Kanbay M,Solak Y,Afsar B,et al.Serum uric acid and risk for acute kidney injury following contrast.Angiology,2017,68(2):132-144.
• [21]Erol T,Tekin A,Kat?rc?ba??MT,et al.Efficacy of allopurinol pretreatment for prevention of contrast-induced nephropathy:a randomized controlled trial.Int J Cardiol,2013,167(4):1396-1399.
• [22]Kumar A,Bhawani G,Kumari N,et al.Comparative study of renal protective effects of allopurinol and N-acetyl-cysteine on contrast induced nephropathy in patients undergoing cardiac catheterization.J Clin Diagn Res,2014,8(12):HC03-HC07.
• [23]Gustafsson D,Unwin R.The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease,morbidity and mortality.BMC Nephrol,2013,14:164.
• [24]Chen JH,Chuang SY,Chen HJ,et al.Serum uric acid level as an independent risk factor for all-cause,cardiovascular,and ischemic stroke mortality:a Chinese cohort study.Arthritis Rheum,2009,61(2):225-232.
• [25]Maxwell AJ,Bruinsma KA.Uric acid is closely linked to vascular nitric oxide activity.Evidence for mechanism of association with cardiovascular disease.J Am Coll Cardiol,2001,38(7):1850-1858.
• [26]Ho WJ,Tsai WP,Yu KH,et al.Association between endothelial dysfunction and hyperuricaemia.Rheumatology(Oxford),2010,49(10):1929-1934.
• [27]Kanbay M,Segal M,Afsar B,et al.The role of uric acid in the pathogenesis of human cardiovascular disease.Heart,2013,99(11):759-766.
• [28]Kanellis J,Kang DH.Uric acid as a mediator of endothelial dysfunction,inflammation,and vascular disease.Semin Nephrol,2005,25(1):39-42.
• [29]Navarese EP,Gurbel PA,Andreotti F,et al.Prevention of contrast-induced acute kidney injury in patients undergoing cardiovascular procedures-a systematic review and network metaanalysis.PLoS One,2017,12(2):e0168726.